Valérie Paradis

Replication stress triggered by nucleotide pool imbalance drives DNA damage and cGAS-STING pathway activation in NAFLD.

P. Revy, K. Unger, P. Gual, 2022, Developmental cell.

Arterial Calcifications in Patients with Liver Cirrhosis Are Linked to Hepatic Deficiency of Pyrophosphate Production Restored by Liver Transplantation

G. Leftheriotis, A. Iannelli, P. Gual, 2022, Biomedicines.

The triglycerides and glucose (TyG) index: a new marker associated with nonalcoholic steatohepatitis (NASH) in obese patients.

E. Renard, M. Picot, F. Galtier, 2022, Diabetes & metabolism.

MAIT cell inhibition promotes liver fibrosis regression via macrophage phenotype reprogramming

J. Wan, O. Lantz, S. Lotersztajn, 2023, Nature Communications.

Selective disruption of NRF2-KEAP1 interaction leads to NASH resolution and reduction of liver fibrosis in mice

L. Vuillard, P. Delerive, K. Seedorf, 2022, JHEP reports : innovation in hepatology.

Monoacylglycerol lipase reprograms hepatocytes and macrophages to promote liver regeneration

J. Wan, H. Guillou, M. le Gall, 2023, JHEP reports : innovation in hepatology.

AGR2 protein expression in colorectal tumour epithelialcompartment

A. Lièvre, E. Ogier-Denis, T. Hupp, 2022, Gut.

Rivaroxaban Prophylaxis in Noncirrhotic Portal Vein Thrombosis

V. Vilgrain, D. Valla, F. Durand, 2022, NEJM Evidence.

A new NRF2 activator for the treatment of human metabolic dysfunction-associated fatty liver disease

P. Delerive, S. Laouirem, M. Albuquerque, 2023, JHEP reports : innovation in hepatology.

Endothelial autophagy is not required for liver regeneration after partial hepatectomy in mice with fatty liver

C. Casteleyn, M. Tanguy, P. Rautou, 2023, Liver international : official journal of the International Association for the Study of the Liver.